Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.
about
Extended-spectrum beta-lactamases: a clinical updatePseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-{beta}-lactamase from different Italian hospitals.Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strainsExtended-spectrum-beta-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program.Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa.Nosocomial infections caused by multidrug-resistant isolates of pseudomonas putida producing VIM-1 metallo-beta-lactamaseMechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy.Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impactEvaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa.Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates.Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex.Emerging extended-spectrum beta-lactamases in Proteus mirabilisHigh prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea.Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa.Nosocomial outbreak of extended-spectrum beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens, Greece.Antimicrobial Susceptibility and Clonal Relation Between Acinetobacter baumannii Strains at a Tertiary Care Center in Turkey.Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide surveyExtended-spectrum beta-lactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in FranceHorizontol dissemination of TEM- and SHV-typr beta-lactamase genes-carrying resistance plasmids amongst clonical isolates of Enterobacteriaceae.Widespread detection of VEB-1-type extended-spectrum beta-lactamases among nosocomial ceftazidime-resistant Pseudomonas aeruginosa isolates in Sofia, Bulgaria.
P2860
Q24534999-1494FA57-583F-4573-8624-9BECAF734799Q33236778-EB6F4A83-454A-4256-8A34-A26FE29E1C83Q33554729-C8BB179F-7ABA-4A94-97CC-853149D9AC30Q33613660-F7A0CA18-EA64-4E1F-B438-A563E2BFD800Q33938190-6D39307D-9E78-46E2-8166-EFBE25F72F53Q34113057-2C03DD54-6C21-4CEE-87D5-9B4C8F3B7C35Q34437404-1DF79D4F-90A4-44E3-8201-2F7037694151Q34439079-A25CA51D-A8C6-4A32-B1DD-A4FE872774C3Q34555131-1CC7376B-61C1-4AFE-9E2D-134F27F31F39Q34782040-525E4499-5B98-4CA7-8BA3-E0585C4AF448Q35183983-5973E469-93C5-4988-9870-D582D7DD63FAQ35667778-127A6A35-7CD7-41D4-8700-6C316C77333AQ35690585-55262603-FCAA-487C-BA05-9FF46CAC9D7DQ35840852-AFF6CC98-C772-4B3B-A2A3-9C94155683D8Q36098603-22A17D2D-D0CA-48FE-80AD-9972E85FA398Q39697527-256877B2-0478-40FF-B913-EFA04CF41498Q39746493-4B1888A5-DD54-4FCA-84F8-D18585752538Q39848627-FD4833DD-C227-4373-839D-DA92D28525A0Q40882602-E4E5EAB3-C022-42A4-9A69-A7CBC9BFE3C4Q41368137-6A3D56BF-D3A3-4E9A-88B8-7320D92F1103Q41807595-1B8314EB-E7CB-4466-9275-6F34736E90BCQ41910163-A283D7BA-A31F-4D49-9C4A-6E38532EFC5BQ42593622-2452ABBD-03A7-4C9D-A796-3EA577E3F100Q43928565-4E3DA9A2-132F-49F1-9FC7-225BB7F8ED29
P2860
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dynamics of a nosocomial outbr ...... ended-spectrum beta-lactamase.
@ast
Dynamics of a nosocomial outbr ...... ended-spectrum beta-lactamase.
@en
type
label
Dynamics of a nosocomial outbr ...... ended-spectrum beta-lactamase.
@ast
Dynamics of a nosocomial outbr ...... ended-spectrum beta-lactamase.
@en
prefLabel
Dynamics of a nosocomial outbr ...... ended-spectrum beta-lactamase.
@ast
Dynamics of a nosocomial outbr ...... ended-spectrum beta-lactamase.
@en
P2093
P2860
P921
P1476
Dynamics of a nosocomial outbr ...... ended-spectrum beta-lactamase.
@en
P2093
Amicosante G
Lombardi G
Mantengoli E
Rossolini GM
P2860
P304
P356
10.1128/JCM.39.5.1865-1870.2001
P407
P577
2001-05-01T00:00:00Z